Primary Health Care Limited
.png)
PRY Details
-
Management concerns might pose pressure: Primary Health Care Limited (ASX: PRY) stock surged over 5.12% like its peers on May 16, 2016 driven by the news of the Australian government's plan to introduce legislation to control rents for pathology center sites. On the other hand, Mr Peter Gregg who is the Chief Executive Officer has been facing ASIC investigation regarding Leighton Holdings under his role as CFO for Leighton Holdings. Moreover, PRY delivered an outstanding performance of 50.7% (as of May 13, 2016) in the last three months alone placing them at higher levels.
-
Recommendation: We give an “Expensive” recommendation on the stock at the current price of $3.60
Sonic Healthcare Limited
.png)
SHL Details
-
Higher valuations: Sonic Healthcare Limited (ASX: SHL) also rallied over 5% on May 16, 2016 as the group was also among the stocks to benefit from the Australian government's move on controlling rents for pathology center sites. But, Sonic Healthcare stock price has already rallied over 14.6% (as of May 13, 2016) in the last three months driven by its solid half year of 2016 performance, with revenues and EBITDA rising by 21.8% and 15.5%, respectively. However, the stock is trading at a relatively higher P/E.
-
Recommendation: We recommend that the stock is “Expensive” at the current price of $21.79
Sirtex Medical Limited
.png)
SRX Details
-
Appointed Kevin Richardson as CEO for America region: Sirtex Medical Limited (ASX: SRX) rallied over 3.05% on May 16, 2016 on track with its peers which rallied on the back of Australian government's efforts to control rents for pathology center sites. Moreover, the group appointed Mr Kevin Richardson as Chief Executive Officer for Americas starting from 1st July, 2016. This move indicates the group’s solid efforts to tap the market from Americas further.
-
Recommendation: We give a “Buy” on SRX at the current price of $30.62
.png)
Performance Highlights (Source: Company Reports)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.